Adeno-Associated Viral Vectors in Neuroscience Research

被引：76
|
作者：
Haggerty, David L. [1 ]
Grecco, Gregory G. [1 ,2 ]
Reeves, Kaitlin C. [1 ]
Atwood, Brady [1 ,3 ]
机构：
[1] Indiana Univ Sch Med, Dept Pharmacol & Toxicol, 320 West 15th St,NB-400C, Indianapolis, IN 46202 USA
[2] Indiana Univ Sch Med, Med Scientist Training Program, Indianapolis, IN 46202 USA
[3] Stark Neurosci Res Inst, Indianapolis, IN 46202 USA
来源：
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT | 2020年 / 17卷
关键词：
GENE-THERAPY VECTOR; PARKINSONS-DISEASE; VIRUS AAV; DOUBLE-BLIND; SEROTYPES; OPEN-LABEL; EFFICIENT TRANSDUCTION; ALIPOGENE TIPARVOVEC; ALZHEIMERS-DISEASE; SUBSTANTIA-NIGRA;
D O I：
10.1016/j.omtm.2019.11.012
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
Adeno-associated viral vectors (AAVs) are increasingly useful preclinical tools in neuroscience research studies for interrogating cellular and neurocircuit functions and mapping brain connectivity. Clinically, AAVs are showing increasing promise as viable candidates for treating multiple neurological diseases. Here, we briefly review the utility of AAVs in mapping neuro-circuits, manipulating neuronal function and gene expression, and activity labeling in preclinical research studies as well as AAV-based gene therapies for diseases of the nervous system. This review highlights the vast potential that AAVs have for transformative research and therapeutics in the neurosciences.
引用
收藏
页码：69 / 82
页数：14
相关论文
共 50 条
  • [21] Assessment of quality attributes for adeno-associated viral vectors
    Tustian, Andrew D.
    Bak, Hanne
    BIOTECHNOLOGY AND BIOENGINEERING, 2021, 118 (11) : 4186 - 4203
  • [22] A role for adeno-associated viral vectors in gene therapy
    Coura, Renata dos Santos
    Nardi, Nance Beyer
    GENETICS AND MOLECULAR BIOLOGY, 2008, 31 (01) : 1 - 11
  • [23] Enhancing transduction of the liver by adeno-associated viral vectors
    Nathwani, A. C.
    Cochrane, M.
    McIntosh, J.
    Ng, C. Y. C.
    Zhou, J.
    Gray, J. T.
    Davidoff, A. M.
    GENE THERAPY, 2009, 16 (01) : 60 - 69
  • [24] Optimization of Affinity Purification for Adeno-Associated Viral Vectors
    Zhao, Huiren
    Wang, Songli
    Meisen, W. Hans
    MOLECULAR THERAPY, 2021, 29 (04) : 87 - 87
  • [25] Adeno-associated viral vectors: A review of biosafety issues
    Flotte, TR
    Afione, SA
    GENE DELIVERY SYSTEMS: A STATE-OF-THE-ART REVIEW, 1996, : 93 - 97
  • [26] Adeno-associated viral vectors for Parkinson's disease
    Muramatsu, S
    Wang, LJ
    Ikeguchi, K
    Fujimoto, K
    Nakano, I
    Okada, T
    Mizukami, H
    Hanazono, Y
    Kume, A
    Nakano, I
    Ozawa, K
    VIRAL VECTORS FOR TREATING DISEASES OF THE NERVOUS SYSTEM, 2003, 55 : 205 - 222
  • [27] TARGETING ADENO-ASSOCIATED VIRAL VECTORS TO FRACTURES AND THE SKELETON
    Lee, L.
    Peacock, L.
    Lisowski, L.
    Little, D.
    Munns, C.
    Schindeler, A.
    CYTOTHERAPY, 2019, 21 (05) : E2 - E2
  • [28] Adeno-associated viral vectors:: Principles and in vivo use
    Danos, O
    TARGETING OF DRUGS: STRATEGIES FOR GENE CONSTRUCTS AND DELIVERY, 2000, 323 : 10 - 18
  • [29] Adeno-associated viral vectors deliver gene vaccines
    Wei, Lai
    Yu, Peng
    Wang, Haomeng
    Liu, Jiang
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2025, 281
  • [30] Cellular transduction mechanisms of adeno-associated viral vectors
    Berry, Garrett Edward
    Asokan, Aravind
    CURRENT OPINION IN VIROLOGY, 2016, 21 : 54 - 60
12345